Siddhartha Dutta
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 14
- SARS-CoV-2 and COVID-19 Research 11
-
- Antibiotic Use and Resistance 4
- Health top 10%
- Modeling and Simulation top 5%
- Neurology top 10%
-
- Pharmaceutical Practices and Patient Outcomes 7
-
- Pharmaceutical Economics and Policy 5
-
- COVID-19 and Mental Health 4
-
- Pharmaceutical studies and practices 4
-
- Diabetes Treatment and Management 4
- Co-authors
- Jaykaran CharanMainul HaquePankaj BhardwajRimple Jeet KaurDharamveer YadavSalequl IslamPraveen SharmaSanjeev Misra
- Journals
- Journal of Inflammation Research (3 papers)Expert Opinion on Drug Safety (3 papers)Infection and Drug Resistance (2 papers)
- Partner nations
- IndiaMalaysiaBangladesh
In The Last Decade
Siddhartha Dutta
64 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Infectious Diseases 438
- Applied Microbiology and Biotechnology 41
- Health 103
- Modeling and Simulation 54
- Neurology 116
Countries citing papers authored by Siddhartha Dutta
This map shows the geographic impact of Siddhartha Dutta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siddhartha Dutta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siddhartha Dutta more than expected).
Fields of papers citing papers by Siddhartha Dutta
This network shows the impact of papers produced by Siddhartha Dutta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siddhartha Dutta. The network helps show where Siddhartha Dutta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Siddhartha Dutta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 1 | |
| 6 | Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetesbreakdown → | 2023 | 93 |
| 7 | 2022 | 0 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 23 | |
| 11 | 2021 | 27 | |
| 12 | 2021 | 180 | |
| 13 | Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database | 2020 | 6 |
| 14 | 2020 | 9 | |
| 15 | 2020 | 52 | |
| 16 | 2020 | 2 | |
| 17 | 2020 | 9 | |
| 18 | Rheumatic Fever: A Review on Pathogenesis, Modified Diagnosis and Pharmacotherapy | 2019 | 1 |
| 19 | Male mating tactics and mating activity in freshwater prawn, Macrobrachium dayanum (Henderson, 1893) Paleomonidae: Caridae | 2012 | 2 |
| 20 | 2004 | 4 |
About Siddhartha Dutta
Siddhartha Dutta is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology and Infectious Diseases, having authored 74 papers that have together received 1.0k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (14 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Pharmaceutical Practices and Patient Outcomes (7 papers), Pharmaceutical Economics and Policy (5 papers), COVID-19 and Mental Health (4 papers), Pharmaceutical studies and practices (4 papers), Diabetes Treatment and Management (4 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Infectious Diseases (438 citations), Applied Microbiology and Biotechnology (41 citations) and Health (103 citations). Siddhartha Dutta has collaborated with scholars based in India, Malaysia and Bangladesh. Frequent co-authors include Jaykaran Charan, Mainul Haque, Pankaj Bhardwaj, Rimple Jeet Kaur, Dharamveer Yadav, Salequl Islam, Praveen Sharma, Sanjeev Misra, Sneha Ambwani and Prasenjit Mitra. Their work appears in journals such as Journal of Inflammation Research, Expert Opinion on Drug Safety, Infection and Drug Resistance, Expert Review of Anti-infective Therapy and Australian & New Zealand Journal of Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.